Friday, April 29, 2022

Non-Invasive Prenatal Testing (NIPT) Market Worth $13.14 Billion by 2027, Growing at a CAGR of 17.1% from 2019

 

The non-invasive prenatal testing market is expected to grow at a CAGR of 17.1% from 2019 to 2027 to reach $13.14 billion by 2027.

With the emergence of innovative diagnostic and screening techniques, several methods of genetic testing are gaining popularity. These include carrier testing, preimplantation genetic diagnosis / screening (PGD / PGS), non-invasive prenatal testing (NIPT), paternity testing, and newborn screening. Technological advancements in the healthcare industry such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing and molecular research have opened new and promising pathways to combat genetic diseases and reduce the overall global economic burden.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5068

Among the innumerable advancements witnessed by the industry, non-invasive prenatal testing stands as one of the most distinctive technologies in curbing the concerns related to genetic diseases. NIPT a novel genetic screening method based on the analysis of cell-free fetal deoxyribose nucleic acid (cff-DNA) in the maternal plasma is considered as a valuable test for pregnant women, which provides early diagnosis of genetic disorders in fetus.

Further, advancements in genome sequencing technologies have reduced the turnaround time and lowered complexities associated with diagnosis. NGS technology provides several avenues to develop non-invasive diagnostic procedures for an early and accurate detection of various genetic disorders. This is driving several companies to invest in research and development of NGS-based NIPT products and develop innovative solutions for the market. For instance, in January 2019, Yourgene Health plc (U.K.) launched the Sage 32 plex test which uses Thermo Fisher’s Ion Torrent sequencing technology to detect placental cff-DNA in a maternal blood sample. Similarly, in September 2018, Yourgene Health formerly known as Premaitha Health plc. (U.K.) partnered with Illumina Inc. (U.S.) to use the Illumina’s sequencing technology for the NIPT test developed by Premaitha.

The growth in the overall NIPT market is majorly driven by factors like shifting trend towards childbirth at an advanced maternal age, increasing prevalence of chromosomal abnormalities, availability of reimbursement for NIPT, and development of advanced technologies for non-invasive parenteral testing. However, the high cost of the non-invasive prenatal screening techniques hinders the growth of this market.Some of the key players operating in the global non-invasive prenatal testing market are Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), PerkinElmer Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Eurofins LifeCodexx (Germany), Natera, Inc. (U.S.), Igenomix S.L (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Yourgene Health plc (U.K.).

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5068

Thursday, April 28, 2022

Diabetes Care Devices Market Worth $31.9 Billion by 2028 - Exclusive Report by Meticulous Research®

 According to a new market research report, titled “Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] - Global Forecast to 2028” published by Meticulous Research®, the diabetes care devices market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

As the prevalence of diabetes is increasing globally, self-management of diabetic treatments has become necessary to avoid long-term complications and fatalities. Diabetes care devices play an important role in managing diabetes as they enable patients to record and track their blood glucose levels all day long and administer the insulin doses according to the insulin levels.

The key factors driving the overall diabetes care devices market are the rising obesity cases, unhealthy and sedentary lifestyle, increasing prevalence of diabetes, and development of new insulin delivery systems. However, some limitations of diabetes care devices are their high costs and accessibility in low-middle income countries.

Impact of COVID-19 on Diabetes Care Devices Market

The COVID-19 pandemic has severely impacted the diabetes care devices market. COVID-19 patients had higher blood glucose levels due to the use of steroids for the COVID-19 treatment. In 2020, the increase in the number of individuals suffering from diabetes due to COVID-19 expanded the income of the central participants in the diabetes care division. Many players in the market presented new progressed diabetes care devices and association arrangements for diabetes care devices.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/diabetes-care-devices-market-3438

Scope of the Report:

Diabetes Care Devices Market, by Type

  • Diabetes Monitoring Devices
  • Insulin Delivery Devices

Diabetes Care Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

     Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research

Monday, April 25, 2022

INSECT PROTEIN MARKET WORTH $9.46 BILLION BY 2030

  • Whole Insects
  • Insect Powder
  • Insect Meal
  • Crickets
  • Black Soldier Flies
  • Mealworms
  • Buffalo Worms
  • Grasshoppers
  • Ants
  • Silkworms
  • Cicadas
  • Other Insect proteins
  • Food & Beverages
  • Processed Whole Insect
  • Processed Insect Powder
  • Protein Bars & Protein Shakes
  • Baked Product & Snacks
  • Insect Confectioneries
  • Insect Beverages
  • Other Food & Beverage Applications
  • Feed
  • Animal Feed
  • Aquaculture Feed
  • Pet Food
  • Human Consumption
  • Animal Nutrition
  • North America
  • U.S.
  • Canada
  • Europe
  • Netherlands
  • Belgium
  • France
  • Denmark
  • Finland
  • Germany
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Thailand
  • China
  • South Korea
  • Vietnam
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa
  • Middle East & Africa
  • Which are the high-growth market segments in terms of product, insect type, application, end use, and region/country?
  • What was the historical market size for insect protein across the globe?
  • What are the market forecasts and estimates for 2022–2030?
  • What are the major drivers, restraints, opportunities, and trends for the global insect protein market?
  • Who are the major players in the global insect protein market?
  • How is the competitive landscape, and who are the market leaders in the global insect protein market?
  • What are the recent developments in the global insect protein market?
  • What are the geographical trends and high-growth regions/countries?
  • Who are the local emerging players in the global insect protein market, and how do they compete with the global players?

Wednesday, April 20, 2022

Speech and Voice Recognition Market to be Worth $26.79 billion by 2025

 According to a new market research report titled, Speech and Voice Recognition Market by Type (Speech and Voice Recognition), End User (Automotive, Healthcare, BFSI, Education, Legal), Technology (Artificial Intelligence and Non-Artificial Intelligence), and Geography — Global Forecast to 2025,” published by Meticulous Research®, the speech and voice recognition market is expected to grow at a CAGR of 17.2% from 2019 to 2025 to reach $26.79 billion by 2025.

  • Speech Recognition
  • Automatic Speech Recognition
  • Text-to-Speech
  • Voice Recognition
  • Speaker Identification
  • Speaker Verification
  • Artificial Intelligence
  • Non-artificial Intelligence
  • Automotive
  • Healthcare
  • BFSI
  • Education
  • Hospitality
  • Government and Public Services
  • Manufacturing/Enterprises
  • Retail and E-Commerce
  • Legal
  • Consumer Electronics
  • Military and Defense
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa